BetterLife Pharma Inc. (CSE:BETR)

Market Cap	35.50M +137.6%
Revenue (ttm)	n/a
Net Income	-1.89M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	42,071
Open	0.2300
Previous Close	0.2300
Day's Range	0.2300 - 0.2400
52-Week Range	0.0400 - 0.2500
Beta	0.28
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 25, 2026

About BetterLife Pharma

BetterLife Pharma Inc., a biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight viral infections. The company offers a product pipeline that includes BETR-001, a non-hallucinogenic neuroplastogen based on 2-bromo-lysergic acid diethylamide (2-bromo-LSD), intended for the treatment of major depressive disord...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 7
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: BETR

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 21, 2026

Data Sources Report a data error